NMI: a potential biomarker for tumor prognosis and immunotherapy
N-Myc and STAT Interactor protein (NMI) is an interferon inducible protein participating in various cellular activities, and is widely involved in the process of tumorigenesis and progression. Studies have shown that the loss of NMI expression in breast cancer can promote its progression by inducing...
Saved in:
Main Authors: | Teng He (Author), Yinbiao Qiao (Author), Qi Yang (Author), Jie Chen (Author), Yongyuan Chen (Author), Xiaoke Chen (Author), Zhixing Hao (Author), Mingjie Lin (Author), Zheyu Shao (Author), Pin Wu (Author), Feng Xu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-cultural adaptation of the Neonatal Medical Index (NMI) to Brazil
by: Marcelo Dias, et al.
Published: (2024) -
Identification of VRK1 as a Novel Potential Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
by: He X, et al.
Published: (2024) -
Anti-amyloid immunotherapy in Alzheimer's disease: The new dawn emerging from 179 clinical trials
by: Longmin Fan, et al.
Published: (2024) -
A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs
by: Bo Song, et al.
Published: (2022) -
Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice
by: Xiaoying Lin, et al.
Published: (2023)